Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer

被引:40
|
作者
Yang, Fan [1 ]
Liu, Ye-huan [1 ]
Dong, Si-yang [1 ]
Yao, Zhi-han [1 ]
Lv, Lin [1 ]
Ma, Rui-min [1 ]
Dai, Xuan-xuan [1 ]
Wang, Jiao [2 ]
Zhang, Xiao-hua [1 ]
Wang, Ou-chen [1 ]
机构
[1] Wenzhou Med Univ, Dept Surg Oncol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Triple-negative breast cancer; Long non-coding RNA; RMST; Expression profile; LONG NONCODING RNAS; TRANSCRIPTOME ANALYSIS; IDENTIFICATION; EXPRESSION; SUBTYPES;
D O I
10.1016/j.gene.2016.07.002
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with unfavorable outcome. It is urgent to explore novel biomarkers and potential therapeutic targets in this malignancy. Increasing knowledge of long noncoding RNAs (lncRNAs) significantly deepens our understanding of cancer biology. Here, we sequenced eight paired TNBC tumor tissues and non-cancerous tissues, and validated significantly differentially expressed IncRNAs. Gene ontology (GO) and pathway analysis were used to investigate the function of differentially expressed mRNAs. Further, potential core lncRNAs in TNBC were identified by co-expression networks. Kaplan-Meier analysis also indicated that breast cancer patients with lower expression level of rhabdomyosarcoma 2 associated transcript (RMST), one of the potential core IncRNAs, had worse overall survival. To the best of our knowledge, it was the first report that RMST was involved in breast cancer. Our research provided a rich resource to the research community for further investigating lncRNAs functions and identifying lncRNAs with diagnostic and therapeutic potentials in TNBC. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:471 / 477
页数:7
相关论文
共 50 条
  • [31] Identification of Metastasis-Associated Genes in Triple-Negative Breast Cancer Using Weighted Gene Co-expression Network Analysis
    Xie, Wenting
    Du, Zhongshi
    Chen, Yijie
    Liu, Naxiang
    Zhong, Zhaoming
    Shen, Youhong
    Tang, Lina
    EVOLUTIONARY BIOINFORMATICS, 2020, 16
  • [32] Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis
    Huan-Ming Hsu
    Chi-Ming Chu
    Yu-Jia Chang
    Jyh-Cherng Yu
    Chien-Ting Chen
    Chen-En Jian
    Chia-Yi Lee
    Yueh-Tao Chiang
    Chi-Wen Chang
    Yu-Tien Chang
    Scientific Reports, 9
  • [33] Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
    Yao-Yin Chang
    Wen-Hung Kuo
    Jui-Hui Hung
    Chien-Yueh Lee
    Yung-Hua Lee
    Ya-Chu Chang
    Wen-Chun Lin
    Cheng-Ying Shen
    Chiun-Sheng Huang
    Fon-Jou Hsieh
    Liang-Chuan Lai
    Mong-Hsun Tsai
    King-Jen Chang
    Eric Y Chuang
    Molecular Cancer, 14
  • [34] Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
    Chang, Yao-Yin
    Kuo, Wen-Hung
    Hung, Jui-Hui
    Lee, Chien-Yueh
    Lee, Yung-Hua
    Chang, Ya-Chu
    Lin, Wen-Chun
    Shen, Cheng-Ying
    Huang, Chiun-Sheng
    Hsieh, Fon-Jou
    Lai, Liang-Chuan
    Tsai, Mong-Hsun
    Chang, King-Jen
    Chuang, Eric Y.
    MOLECULAR CANCER, 2015, 14
  • [35] Del-1 Expression as a Potential Biomarker in Triple-Negative Early Breast Cancer
    Lee, Soo Jung
    Lee, Jeeyeon
    Kim, Wan Wook
    Jung, Jin Hyang
    Park, Ho Yong
    Park, Ji-Young
    Chae, Yee Soo
    ONCOLOGY, 2018, 94 (04) : 243 - 256
  • [36] The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer
    Ke, Danny Yu Jia
    El-Sahli, Sara
    Wang, Lisheng
    CURRENT CANCER DRUG TARGETS, 2022, 22 (05) : 388 - 403
  • [37] Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
    Xu, Na
    Li, Baohong
    Liu, Yong
    Yang, Cui
    Tang, Siqi
    Cho, William C.
    Huang, Zunnan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Src: a potential target for the treatment of triple-negative breast cancer
    Tryfonopoulos, D.
    Walsh, S.
    Collins, D. M.
    Flanagan, L.
    Quinn, C.
    Corkery, B.
    McDermott, E. W.
    Evoy, D.
    Pierce, A.
    O'Donovan, N.
    Crown, J.
    Duffy, M. J.
    ANNALS OF ONCOLOGY, 2011, 22 (10) : 2234 - 2240
  • [39] Triple-Negative Breast Cancer: Risk Factors to Potential Targets
    Schneider, Bryan P.
    Winer, Eric P.
    Foulkes, William D.
    Garber, Judy
    Perou, Charles M.
    Richardson, Andrea
    Sledge, George W.
    Carey, Lisa A.
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8010 - 8018
  • [40] Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
    Li, Chia-Jung
    Tzeng, Yen-Dun Tony
    Chiu, Yi-Han
    Lin, Hung-Yu
    Hou, Ming-Feng
    Chu, Pei-Yi
    CANCERS, 2021, 13 (12)